Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Batchelor

Showing results (151-160 of 321) with videos related to

Pageof 33
Sort By:
Journal of Neuro-Oncology|October 27, 2015
Neurocognitive effects of proton radiation therapy in adults with low-grade gliomaJanet Cohen Sherman, Mary K Colvin, Sarah M Mancuso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastomaChristine Lu-Emerson, Dan G Duda, Kyrre E Emblem, et al.
Neuro-Oncology|September 29, 2011
Phase I trial of sorafenib in patients with recurrent or progressive malignant gliomaL B Nabors, J G Supko, M Rosenfeld, et al.
Neuro-Oncology|September 2, 2008
High-dose methotrexate for elderly patients with primary CNS lymphomaJay-Jiguang Zhu, Elizabeth R Gerstner, David A Engler, et al.
Journal of Neuro-Oncology|November 5, 2015
Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guidelineBrian V Nahed, Navid Redjal, Daniel J Brat, et al.
Pathology, Research and Practice|September 11, 2016
Deformable image registration between pathological images and MR image via an optical macro imageTakashi Ohnishi, Yuka Nakamura, Toru Tanaka, et al.
Neuro-Oncology|July 10, 2010
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastomaMyrna R Rosenfeld, Marc C Chamberlain, Stuart A Grossman, et al.
Neuro-Oncology|February 11, 2004
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11Tracy T Batchelor, Mark R Gilbert, Jeffrey G Supko, et al.
Nature Reviews. Clinical Oncology|August 13, 2014
Vessel caliber--a potential MRI biomarker of tumour response in clinical trialsKyrre E Emblem, Christian T Farrar, Elizabeth R Gerstner, et al.
Journal of Neuro-Oncology|January 31, 2008
The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastomaDavid J Sher, John W Henson, Bindu Avutu, et al.
Pageof 33

Showing results (151-160 of 321) with videos related to

Sort By:
Pageof 33
Journal of Neuro-Oncology|October 27, 2015
Neurocognitive effects of proton radiation therapy in adults with low-grade gliomaJanet Cohen Sherman, Mary K Colvin, Sarah M Mancuso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastomaChristine Lu-Emerson, Dan G Duda, Kyrre E Emblem, et al.
Neuro-Oncology|September 29, 2011
Phase I trial of sorafenib in patients with recurrent or progressive malignant gliomaL B Nabors, J G Supko, M Rosenfeld, et al.
Neuro-Oncology|September 2, 2008
High-dose methotrexate for elderly patients with primary CNS lymphomaJay-Jiguang Zhu, Elizabeth R Gerstner, David A Engler, et al.
Journal of Neuro-Oncology|November 5, 2015
Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guidelineBrian V Nahed, Navid Redjal, Daniel J Brat, et al.
Pathology, Research and Practice|September 11, 2016
Deformable image registration between pathological images and MR image via an optical macro imageTakashi Ohnishi, Yuka Nakamura, Toru Tanaka, et al.
Neuro-Oncology|July 10, 2010
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastomaMyrna R Rosenfeld, Marc C Chamberlain, Stuart A Grossman, et al.
Neuro-Oncology|February 11, 2004
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11Tracy T Batchelor, Mark R Gilbert, Jeffrey G Supko, et al.
Nature Reviews. Clinical Oncology|August 13, 2014
Vessel caliber--a potential MRI biomarker of tumour response in clinical trialsKyrre E Emblem, Christian T Farrar, Elizabeth R Gerstner, et al.
Journal of Neuro-Oncology|January 31, 2008
The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastomaDavid J Sher, John W Henson, Bindu Avutu, et al.
Pageof 33